Julia Violet Vitale Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Jericho Rd Unit A, Richmond, VT 05477 Phone: 908-246-5110 |
Flowstate Speech And Language Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Jericho Rd Apt A, Richmond, VT 05477 Phone: 631-912-5977 |
Jodi Russell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Collins Mountain Rd, Richmond, VT 05477 Phone: 802-434-7633 |
Susan Empie Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Daniel Ln, Richmond, VT 05477 Phone: 802-434-5214 |
Stephanie Spencer O'leary, M.S. C.C.C.-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1198 Hinesburg Rd, Richmond, VT 05477 Phone: 802-434-4493 |
Shira Habermehl Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Jericho Rd Apt A, Richmond, VT 05477 Phone: 631-912-5977 |
News Archive
When patients arrive in emergency departments and hospitals with symptoms consistent with COVID-19, it's critical to isolate them to avoid the potential spread of infection, but keeping patients isolated longer than needed could delay patient care, take up hospital beds needed for other patients, and unnecessarily use up personal protective equipment.
Health and Human Services Secretary Kathleen Sebelius penned an op-ed last week offering a strong defense of the health law's Independent Payment Advisory Board. Meanwhile, however, the American Medical Association has taken an official position against the panel, and 270 other health care organizations sent a letter to members of Congress expressing their opposition too.
Many patients with terminal or serious illness who have exhausted their treatment options want access to experimental therapies they hope will help them.
Following an August 19 meeting convened by the Forum for Collaborative HIV Research to explore recent findings showing the success of pre-exposure prophylaxis (PrEP), "conference participants urged healthcare providers and the public to await further guidance from the CDC and FDA before considering using PrEP. However, if providers believe that initiating PrEP is urgent for a specific patient, CDC recommends following the cautions and procedures previously published for PrEP use in MSM", a Forum press release states.
› Verified 9 days ago